Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 1;12(1):e6530.
doi: 10.7759/cureus.6530.

Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers

Affiliations

Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers

Ândrea Chaves-Markman et al. Cureus. .

Abstract

Familial hypertrophic cardiomyopathy is an autosomal dominant genetic disease considered the most common cause of sudden cardiac death in individuals under 35 years old, especially the athletes. This study aimed to investigate the association between the presence of late potentials and a family history of sudden death, syncope, and complex ventricular arrhythmias on patients with hypertrophic cardiomyopathy. A case series study was carried out from March 2001 to December 2002, including 22 patients with hypertrophic cardiomyopathy according to transthoracic echocardiogram criteria. Patients on a cardiac pacemaker, right bundle branch block, cardiac transplant, and under no possibilities to realize the exams were excluded. The results showed that asymmetric septal hypertrophy was the most common type (73%), 63% had a positive familial history of hypertrophic cardiomyopathy, 55% sudden cardiac death, and 23% syncope. Also, complex ventricular arrhythmias were detected in 14% and late potentials in 23% of patients. According to this study, the presence of late potentials was not associated with familial sudden death, syncope, and complex ventricular arrhythmias.

Keywords: cardiogenic syncope; familial hypertrophic cardiomyopathy; late potentials; prognostic marker; sudden death.

PubMed Disclaimer

Conflict of interest statement

The authors have declared financial relationships, which are detailed in the next section.

Figures

Figure 1
Figure 1. Patients' echocardiographic characteristics
SAH: septal asymmetrical hypertrophy; MVH: medium-ventricular hypertrophy; CH: concentric hypertrophy; SAH/RV: septal asymmetrical hypertrophy + right ventricular hypertrophy

Similar articles

Cited by

References

    1. Genetic cardiomyopathies. Wilcox JE, Hershberger RE. Curr Opin Cardiol. 2018;33:354–362. - PubMed
    1. Successful knock-in of hypertrophic cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs. Montag J, Petersen B, Flögel AK, et al. Sci Rep. 2018;8:4786. - PMC - PubMed
    1. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Tobita T, Nomura S, Fujita T, et al. Sci Rep. 2018;8:1–11. - PMC - PubMed
    1. Familial hypertrophic cardiomyopathy - Identification of cause and risk stratification through exome sequencing. Biswas A, Das S, Kapoor M, et al. Gene. 2018;660:151–156. - PubMed
    1. A one health approach to hypertrophic cardiomyopathy. Ueda Y, Stern JA. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612186/ Yale J Biol Med. 2017;90:433–448. - PMC - PubMed

LinkOut - more resources